Presentation TCT 2012

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Presenter: Paul Grayburn, Saibal Kar, Ted Feldman, Donald Glower, Elyse Foster, Laura Mauri

January 03, 2012

REGISTER for free or LOG IN to view this content

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Structural Heart

Presentation

TCT 2012

Up Next

Presentation TCT 2012

Impact on the need for permanent pacemaker requirement after CoreValve prosthesis implantation with the new Accutrak delivery Catheter System

Presenter: Antonio J. Mu?oz-Garc?a

January 03, 2012

More slides +

Presentation TCT 2012

Percutaneous Transcatheter Pulmonary Valve Implantation Induces a Reduction of B-Type Natriuretic Peptide at 30 days.

Presenter: Joelle Kefer

January 03, 2012

Presentation

Outcomes After Coronary Stent Implantation in Patients with Metal Allergy

Presenter: S. Romero-Brufau

April 09, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.